[go: up one dir, main page]

TR200201654T2 - Benzamidin türevleri. - Google Patents

Benzamidin türevleri.

Info

Publication number
TR200201654T2
TR200201654T2 TR2002/01654T TR200201654T TR200201654T2 TR 200201654 T2 TR200201654 T2 TR 200201654T2 TR 2002/01654 T TR2002/01654 T TR 2002/01654T TR 200201654 T TR200201654 T TR 200201654T TR 200201654 T2 TR200201654 T2 TR 200201654T2
Authority
TR
Turkey
Prior art keywords
relates
treatment
prevention
blood clotting
clotting disorder
Prior art date
Application number
TR2002/01654T
Other languages
English (en)
Inventor
Asai Fumitoshi
Matsuhashi Hayao
Fujimoto Koichi
Original Assignee
Sankyo Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company Limited filed Critical Sankyo Company Limited
Publication of TR200201654T2 publication Critical patent/TR200201654T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Manufacture Of Alloys Or Alloy Compounds (AREA)

Abstract

Bu bulus, faktör Xa'ya karsi üstün inhibitör aktivitesi olan benzamidin türevleriyle ve farmasötik olarak kabul edilebilir tuzlariyla ilgilidir. Bulus ayrica, kan pihtilasmasiyla ilgili bir bozuklugun önlenmesi veya tedavisi için söz konusu bilesimlerin aktif madde olarak içeren farmasötik terkiplerle de ilgilidir. Bulus, ilaveten kan pihtilasmasiyla ilgili bir bozuklugun önlenmesi veya tedavisi için bir ilacin hazirlanmasinda söz konusu bilesimlerin kullanimiyla da ilgilidir. Ayrica bulus, kan pihtilasmasiyla ilgili bir bozuklugun önlenmesi veya tedavisi için, böyle bir tedaviye ihtiyaci olan bir sicak-kanli hayvana söz konusu birlesimlerden farmasötik olarak etkili bir miktarda verilmesini içeren bir yöntemle ilgilidir. Ayrica, bulus söz konusu bilesimlerin hazirlanmasi için bir prosesle de ilgilidir.
TR2002/01654T 1999-10-28 2000-10-25 Benzamidin türevleri. TR200201654T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30719299 1999-10-28

Publications (1)

Publication Number Publication Date
TR200201654T2 true TR200201654T2 (tr) 2002-12-23

Family

ID=17966162

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01654T TR200201654T2 (tr) 1999-10-28 2000-10-25 Benzamidin türevleri.

Country Status (26)

Country Link
US (3) US6555556B1 (tr)
EP (1) EP1245564B1 (tr)
KR (1) KR100642953B1 (tr)
CN (2) CN1293052C (tr)
AT (1) ATE322479T1 (tr)
AU (1) AU776193B2 (tr)
BR (1) BR0015120A (tr)
CA (1) CA2389156C (tr)
CY (1) CY1106116T1 (tr)
CZ (1) CZ20021432A3 (tr)
DE (1) DE60027204T2 (tr)
DK (1) DK1245564T3 (tr)
ES (1) ES2261248T3 (tr)
HK (1) HK1047431B (tr)
HU (1) HUP0203161A3 (tr)
IL (2) IL149306A0 (tr)
MX (1) MXPA02004218A (tr)
NO (1) NO323147B1 (tr)
NZ (1) NZ518581A (tr)
PL (1) PL354619A1 (tr)
PT (1) PT1245564E (tr)
RU (1) RU2222529C2 (tr)
TR (1) TR200201654T2 (tr)
TW (1) TWI226886B (tr)
WO (1) WO2001030756A1 (tr)
ZA (1) ZA200203278B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE322479T1 (de) * 1999-10-28 2006-04-15 Sankyo Co Benzamidinderivate
HUP0400384A3 (en) * 2001-04-05 2008-08-28 Sankyo Co Benzamidine derivative and pharmaceutical compositions containing them and their use
WO2002089803A1 (fr) * 2001-05-07 2002-11-14 Sankyo Company, Limited Composition d'ionophorese
CN1267416C (zh) * 2002-03-15 2006-08-02 橘生药品工业株式会社 新的5－羟基氨基甲酰亚氨基－2－羟基苯磺酰胺衍生物晶体
ES2333739T3 (es) * 2004-11-23 2010-02-26 Dong Wha Pharmaceutical Co., Ltd. Sal de n-hidroxi-4-(5-(4-(5-isopropil-2-metil-1,3-tiazol-4-il)fenoxi) pentoxi)benzamidina con acido 2-metanosulfonico.
CN103159620A (zh) * 2013-03-28 2013-06-19 广西师范大学 一种2-羟基间苯二甲酸的制备方法
KR20250112249A (ko) 2022-11-22 2025-07-23 키메드 바이오사이언시스 (청두) 컴퍼니 리미티드 융합된 고리 화합물, 이의 접합체 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209270A (en) * 1981-06-19 1982-12-22 Chugai Pharmaceut Co Ltd Proline derivative
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
US5731324A (en) * 1993-07-22 1998-03-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
IL112795A (en) * 1994-03-04 2001-01-28 Astrazeneca Ab Peptide derivatives as antithrombic agents their preparation and pharmaceutical compositions containing them
MX9704059A (es) * 1994-12-02 1997-08-30 Yamanouchi Pharma Co Ltd Derivado de amidinonaftilo novedoso o sal del mismo.
DE4443390A1 (de) * 1994-12-06 1996-06-13 Basf Ag Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
EP0906094B1 (en) * 1996-01-02 2003-06-25 Aventis Pharmaceuticals Inc. Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
NZ334264A (en) * 1996-09-12 2000-08-25 Schering Ag Benzamidine derivatives substituted by cyclic amino acid or cyclic hydroxy acid derivatives and their use as anti-coagulants
TW542822B (en) * 1997-01-17 2003-07-21 Ajinomoto Kk Benzamidine derivatives
CA2361428A1 (en) * 1999-02-11 2000-08-17 Cor Therapeutics, Inc. Inhibitors of factor xa
US6350761B1 (en) * 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
ATE322479T1 (de) * 1999-10-28 2006-04-15 Sankyo Co Benzamidinderivate

Also Published As

Publication number Publication date
KR20020092347A (ko) 2002-12-11
US20040248981A1 (en) 2004-12-09
ZA200203278B (en) 2003-08-26
CN1572882A (zh) 2005-02-02
AU7957400A (en) 2001-05-08
EP1245564A1 (en) 2002-10-02
PL354619A1 (en) 2004-02-09
ES2261248T3 (es) 2006-11-16
RU2222529C2 (ru) 2004-01-27
PT1245564E (pt) 2006-06-30
IL149306A (en) 2007-07-04
WO2001030756A1 (en) 2001-05-03
HK1047431B (en) 2006-07-14
DK1245564T3 (da) 2006-08-14
US6555556B1 (en) 2003-04-29
US20040010009A1 (en) 2004-01-15
HK1047431A1 (en) 2003-02-21
AU776193B2 (en) 2004-09-02
NO323147B1 (no) 2007-01-08
HUP0203161A3 (en) 2003-12-29
IL149306A0 (en) 2002-11-10
CZ20021432A3 (cs) 2002-10-16
EP1245564B1 (en) 2006-04-05
CN1413189A (zh) 2003-04-23
DE60027204T2 (de) 2006-11-23
TWI226886B (en) 2005-01-21
MXPA02004218A (es) 2002-10-17
ATE322479T1 (de) 2006-04-15
CY1106116T1 (el) 2011-06-08
EP1245564A4 (en) 2003-03-05
HUP0203161A2 (hu) 2002-12-28
KR100642953B1 (ko) 2006-11-10
NZ518581A (en) 2004-11-26
CA2389156A1 (en) 2001-05-03
NO20021990D0 (no) 2002-04-26
NO20021990L (no) 2002-06-25
BR0015120A (pt) 2002-06-25
CN1293052C (zh) 2007-01-03
DE60027204D1 (en) 2006-05-18
CA2389156C (en) 2009-05-12

Similar Documents

Publication Publication Date Title
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
DE69931159D1 (de) Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
MX9504415A (es) Eteres antivirales de isoesteres de sustrato de proteasa de aspartato.
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
TR200103153T2 (tr) Yeni bileşimler
EA200000176A1 (ru) Применение физиологически приемлемых соединений, солей и комплексов ванадия
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
TR200201654T2 (tr) Benzamidin türevleri.
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
FR2794976B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
TR200103144T2 (tr) Yeni bileşikler
AU5158000A (en) Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
TR200102236T2 (tr) Kolesterol-düşürme amilinin kullanımı.
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler
PL1668021T3 (pl) Nowe związki tioksylozy, sposób ich przygotowania, zawierające je kompozycje farmaceutyczne i ich zastosowanie w lecznictwie
GEP20033054B (en) 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals
ATE337826T1 (de) Simplifizierte sarcodictyn-derivate als anti- tumor-mittel
HUP9802896A3 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient